Here's the live share price of Dr. Reddy's Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Dr. Reddy's Laboratories has gained 4.20% CAGR. Over the past year, the corresponding return has been -6.51%.
Dr. Reddy's Laboratories’s current P/E of 17.33x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories | 0.06 | -2.91 | -1.09 | 4.33 | -6.51 | 9.69 | 4.20 |
| Sun Pharmaceutical Industries | 0.13 | 3.70 | 6.64 | -4.20 | -6.59 | 18.66 | 27.11 |
| Divi's Laboratories | -0.72 | 9.39 | 13.32 | 12.41 | 12.79 | 26.63 | 14.37 |
| Torrent Pharmaceuticals | 7.33 | 7.09 | 6.94 | 20.01 | 19.56 | 32.23 | 24.55 |
| Cipla | 0.72 | 1.19 | 1.82 | 1.73 | -4.98 | 10.23 | 14.68 |
| Zydus Lifesciences | -2.68 | -3.83 | 1.37 | 8.77 | -2.10 | 28.39 | 16.76 |
| Mankind Pharma | -6.21 | -8.80 | -9.39 | -8.20 | -15.97 | 16.20 | 9.43 |
| Lupin | 1.18 | 4.28 | 3.68 | -1.31 | -5.56 | 42.00 | 16.72 |
| Alkem Laboratories | 2.55 | 2.83 | 18.55 | 14.35 | -0.94 | 20.97 | 15.31 |
| Aurobindo Pharma | 1.00 | 7.49 | 10.40 | -0.72 | -13.37 | 28.55 | 7.88 |
| Abbott India | 1.60 | -1.31 | -10.23 | -1.85 | 3.13 | 15.33 | 13.66 |
| Laurus Labs | 4.87 | 16.63 | 21.91 | 70.82 | 100.60 | 30.45 | 30.52 |
| Glenmark Pharmaceuticals | -2.89 | -4.66 | -9.05 | 29.67 | 10.23 | 63.42 | 30.70 |
| Biocon | 2.59 | 9.45 | 11.15 | 14.06 | 18.80 | 11.04 | -1.67 |
| GlaxoSmithKline Pharmaceuticals | -3.36 | -7.03 | -4.25 | -7.48 | -0.75 | 23.76 | 12.46 |
| Anthem Biosciences | -0.75 | -8.45 | -3.44 | -3.46 | -3.46 | -1.17 | -0.70 |
| Ipca Laboratories | 5.97 | -0.45 | -2.63 | -0.15 | -13.39 | 14.78 | 3.55 |
| Ajanta Pharma | 2.43 | 4.79 | -3.02 | 0.24 | -11.93 | 26.38 | 19.20 |
| Gland Pharma | -2.57 | -3.88 | -2.74 | 33.00 | 5.56 | 2.01 | 0.65 |
| J B Chemicals & Pharmaceuticals | 7.93 | 8.16 | 7.28 | 17.99 | -1.51 | 22.34 | 29.26 |
Over the last one year, Dr. Reddy's Laboratories has declined 6.51% compared to peers like Sun Pharmaceutical Industries (-6.59%), Divi's Laboratories (12.79%), Torrent Pharmaceuticals (19.56%). From a 5 year perspective, Dr. Reddy's Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (27.11%) and Divi's Laboratories (14.37%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,245.52 | 1,209 |
| 10 | 1,261.94 | 1,222.61 |
| 20 | 1,254.09 | 1,237.87 |
| 50 | 1,269.03 | 1,253.04 |
| 100 | 1,273.93 | 1,255.33 |
| 200 | 1,235.23 | 1,251.58 |
In the latest quarter, Dr. Reddy's Laboratories remained same as its previous close in promoter holding, while DII stake increased to 38.82%, FII holding fell to 24.69%, and public shareholding moved down to 9.62% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,21,07,943 | 1.24 | 1,481.65 | |
| 93,22,942 | 2.06 | 1,140.85 | |
| 53,57,429 | 1.41 | 655.59 | |
| 48,86,509 | 0.9 | 597.96 | |
| 46,33,059 | 9.1 | 566.95 | |
| 39,16,074 | 5.91 | 479.21 | |
| 36,55,647 | 0.61 | 447.34 | |
| 36,44,961 | 1.09 | 446.03 | |
| 29,09,812 | 0.52 | 356.07 | |
| 28,14,120 | 1.33 | 344.36 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Oct 31, 2025, 4:29 AM IST | Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Oct 29, 2025, 11:16 PM IST | Dr. Reddy's Labs - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 |
| Oct 25, 2025, 4:12 PM IST | Dr. Reddy's Labs - Announcement Under Regulation 30 - Earnings Call Recordings |
| Oct 24, 2025, 10:33 PM IST | Dr. Reddy's Labs - Announcement Under Regulation 30 - Update On Senior Management Personnel |
| Oct 24, 2025, 10:24 PM IST | Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Investor Presentation |
Dr. Reddy's Laboratories Ltd. is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 23115.40 Cr. and Equity Capital is Rs. 83.40 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Dr. Reddy's Laboratories is ₹1,198.45 as on Nov 10, 2025.
The Dr. Reddy's Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Dr. Reddy's Laboratories is ₹100,024.29 Cr as on Nov 10, 2025.
Today’s highest and lowest price of Dr. Reddy's Laboratories are ₹1,209.45 and ₹1,195.25.
The 52-week high/low is the highest and lowest price at which Dr. Reddy's Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Dr. Reddy's Laboratories is ₹1,404.60 and 52-week low of Dr. Reddy's Laboratories is ₹1,025.90 as on Nov 10, 2025.
The Dr. Reddy's Laboratories has shown returns of -0.57% over the past day, -2.91% for the past month, -1.09% over 3 months, -6.51% over 1 year, 9.69% across 3 years, and 4.2% over 5 years.
P/E ratio of and PB ratio of Dr. Reddy's Laboratories are 17.33 and 2.98 on Nov 10, 2025. While the company gives a dividend yield of 0.67 per annum.